

The effect of amiodarone on the spectral parameters of heart rate variability in patients with various forms of atrial fibrillation
https://doi.org/10.33667/2078-5631-2023-26-41-45
Abstract
In this study, spectral parameters in patients with various forms of atrial fibrillation and the effect of the class III antiarrhythmic drug amiodarone on these parameters were studied. The use of spectral analysis of heart rate variability (hereinafter referred to as HRV) when choosing a drug for the treatment of arrhythmia and arterial hypertension is becoming increasingly widespread in experimental and clinical practice. This method, thanks to the mathematical analysis of the time and frequency characteristics of heart rate variability, allows you to get an idea of slow oscillatory processes that constantly exist in the body and have the properties of autowaves. The use of this method gives an idea of the role of various departments of the autonomic nervous system (sympathetic and parasympathetic), as well as the implementation of humoral mechanisms in the implementation of the chronotropic function of the heart.
About the Authors
O. T. BogovaRussian Federation
Bogova Olga T., MD, aassociate professor, professor of the Dept of Geriatrics and Medical and Social Expertize
SCOPUS Author ID: 57204687262; Researcher ID: F-6450-2019
Moscow
A. V. Sviridenko
Russian Federation
Sviridenko Anna V., cardiologist and functional diagnostic
Moscow
S. S. Puzin
Russian Federation
Puzin Sergey S., postgraduate student of the Dept of Geriatrics and Medical and Social Expertize
Moscow
A. S. Markova
Russian Federation
Markova Alyona S., postgraduate student of the Dept of Geriatrics and Medical and Social Expertize
Moscow
S. N. Puzin
Russian Federation
Puzin Sergey N., academician of the Russian Academy of Sciences, MD, professor, head of the Dept of Geriatrics and Medical and Social Expertize, Russian medical Academy of continuing professional education of Minzdrav of Russia; professor of the Dept of Sports Medicine and Medical Rehabilitation, Sechenovskiy University of Minzdrav of Russia; deputy director of Science, Federal scientific and clinical center for resuscitation and rehabilitation; honored Scientist of the Russian Federation, honored doctor of the Russian Federation
Moscow
References
1. Achkasov E. E., Mashkovsky E. V., Bogova O. T., Puzin S. N.,Sultanova O. A. Myocardial remodeling in ischemic heart disease in sports veterans. Medico-social expertise and rehabilitation. 2013. No. 4. Pp. 10–14. (In Russ.).
2. Baevsky R.M., Ivanov I.I. et al. Analysis of heart rate variability using different electrocardiographic systems (guidelines). Vestnik Aritmologii. 2001; 24: 65–87. (In Russ.).
3. Bogova O.T. Features of management of patients with coronary heart disease in diabetes mellitus / Textbook, RMANPO, FIRO Publishing House, Moscow, 2016. 117 p. (In Russ.).
4. Iskenderov B. G., Rahmatulov F. K. Structural and electrophysiological parameters of cardiac function in paroxysmal atrial fibrillation. Ter archive. 2001; 12: 52–56. (In Russ.).
5. Orlova N.V., Fedulaev Yu.N. School of health for patients with atrial fibrillation CardioSomatics. 2019. Vol. 10, no. 3. Pp. 50–59. (In Russ.).
6. Popova E.P., Bogova O.T., Puzin S.N. et al. The effect of antiarrhythmic drugs on the spectral parameters of heart rate variability in patients with atrial fibrillation. Medical and Social Expertise and Rehabilitation. 2018. Vol. 21, no. 1–2. Pp. 101–104. (In Russ.).
7. Popova E.P., Bogova O.T., Chandirli S.A., Puzin S.N., Sychev D.A., Fisenko V.P. The effect of amiodarone on heart rate variability in elderly and senile patients with different forms of atrial fibrillation. Successes of gerontology. 2019. Vol. 32, no. 6. Pp. 1011–1016. (In Russ.).
8. Popova E.P., Bogova O.T., Puzin S.N., Fisenko V.P. The importance of the autonomic nervous system in the pathogenesis of atrial fibrillation. Russian Journal of Cardiology. 2020. Vol. 25, no. 7. pp. 187–193. (In Russ.).
9. Puzin S.N., Bogova O.T., Odebaeva R., Potapov V.N., Chandirli S.A., Shurgaya M.A., Korshikova Yu.I. Rehabilitation of patients with coronary heart disease. Bulletin of the All-Russian Society of Specialists in Medical and Social Expertise, rehabilitation and rehabilitation industry. 2014. No. 2. Pp. 6–9. (In Russ.).
10. Puzin S. N., Shurgaya M. A., Chandirli S. A., Bogova O. T., Potapov V. N.R., Tairov G. M. Aspects of medical and social rehabilitation of patients with hypertension. Medical and social expertise and rehabilitation. 2014. No. 1. Pp. 10–15. (In Russ.).
11. Puzin S. N., Grashchenkova A.N., Bogova O. T. Rehabilitation of patients who have suffered a myocardial infarction on an outpatient basis. Medical Alphabet. 2020. No. 2. Pp. 52–53. (In Russ.).
12. Storozhakov G.I., Chukaeva I.I., Alexandrov A.A., Bogova O.T. et.al. Polyclinic therapy. Moscow: GEOTAR-Media, 2007. 701 p. (In Russ.).
13. Sychev D.A., Zhuchkov A.V., Bogova O.T., Ilyina E.S. Falls of elderly and senile patients: contribution of medicines. Clinical gerontology. 2017. Vol. 23, no. 3–4. Pp. 56–64. (In Russ.).
14. Fleishman A.N., Filimonov S.N., Klimina N.V. A new method of selecting drugs for the treatment of arterial hypertension based on spectral analysis of heart rate variability. Ter. Archive. 2001. No. 12. Pp. 33–39. (In Russ.).
15. Akselrod S. Eds M. Malik, A.J. Camm. Components of heart rate variability. Basis studies. In: Heart Rate Variability. Armonk. N.-Y. Futura Pablishity. Comp. Inc. 1995. Р. 147–163.
16. Gal P., Elvan A., Rossi P. et al. Effect of parasympathetic nerve stimulation on atrial and atrioventricular nodal electrophysiological characteristics. Int. J. Cardiol. 2016. Vol. 205. P. 83–85.
17. Hanley C.M., Robinson V.M., Peter R. Kowey P.R. Status of Antiarrhythmic Drug Development for Atrial Fibrillation. New Drugs and New Molecular Mechanisms. Circ. Arrhythm Electrophysiol. 2016. Vol. 9, nо. 3. P. 1–9.
18. Hohendanner F., Heinzel F.R., Blaschke F. et al. Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure. Heart Fail Rev. 2018. Vol. 23, nо. 1. P. 27–36.
19. Kirchhof P., Breithardt G., Bax J. et al. A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network. European Heart Rhythm Association consensus conference. Europace. 2016. Vol. 18, nо. 1. P. 37–50.
20. Lok N.S., Lau C.P. Abnormal vasovagal reaction, autonomic function, and heart rate variability in patients with paroxysmal atrial fibrillation. Pacing Clin. Electrophysiol. 1998. Vol. 21, nо. 2. P. 386–395.
21. Patel P.A., Ali N., Hogarth A., Tayebjee M.H. Management strategies for atrial fibrillation. J.R. Soc. Med. 2017. Vol. 110, nо. 1. P. 13–22.
22. Stavrakis S., Humphrey M.B., Scherlag B.J. et al. Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation. J. Am. Coll. Cardiol. 2015. Vol. 65. P. 867–75.
23. Task Forse of the European Society of Cardiology and the North American Society of Paciety of Pacing and Electrophysiology. Heart rate variability. Standarts of measurements, physiological interpretation and clinical use. Circulation. 1996. Nо. 93. P. 1043–1065.
24. Wang Z., Page P., Nattel S. Mechanism of flecainide’s antiarrhythmic action in experimental atrial fibrillation. Circ. Res. 1992. Vol. 71, nо. 2. P. 271–287.
25. Jaïs P., Haïssaguerre M., Shah D.C., Chouairi S., Gencel L., Hocini M. et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997; 95 (3): 572–576.
Review
For citations:
Bogova O.T., Sviridenko A.V., Puzin S.S., Markova A.S., Puzin S.N. The effect of amiodarone on the spectral parameters of heart rate variability in patients with various forms of atrial fibrillation. Medical alphabet. 2023;(26):41-45. (In Russ.) https://doi.org/10.33667/2078-5631-2023-26-41-45